You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》內地CDMO企業凱萊英獲中證監批準來港上市
阿思達克 09-23 15:09
凱萊英(002821.SZ)公佈,近日收到中國證監會發出具《關於覈準凱萊英醫藥集團(天津)股份有限公司發行境外上市外資股的批覆》,覈準公司發行不超過4,923.88萬股境外上市外資股,完成本次發行後可於香港主板上市。 根據官網資料顯示,凱萊英爲內地CDMO(醫藥合同定製研發生產)企業,提供新藥研發及生產一站式服務,目前於全球設有8個研發生產基地及17家公司,業務範圍覆蓋臨牀早期到商業化階段,包括高級中間體、原料藥、製劑等的研發、cGMP生產及臨牀研究服務。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account